(3S,5S,6R)-3-Amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one
- CAS
- 1375794-69-6
- Formula
- C14H17F3N2O
- MW
- 286.29 g/mol
VQ-045119
Impurity reference standards
Ubrogepant impurities & reference standards
Characterised Ubrogepant impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
7reference materials
COAHPLC · NMR · MS on request
![(R)-2'-Oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic Acid chemical structure](/media/structures/JZRARRAPRCNVSS-OAHLLOKOSA-N.svg)
(R)-2'-Oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic Acid
- CAS
- 2568065-21-2
- Formula
- C15H11N3O3
- MW
- 281.27 g/mol
VQ-028575
![(S)-1'-(tert-Butyl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one chemical structure](/media/structures/QJYYBHIJWFNBGR-SFHVURJKSA-N.svg)
(S)-1'-(tert-Butyl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one
- CAS
- 2408280-91-9
- Formula
- C18H19N3O
- MW
- 293.4 g/mol
VQ-044818
![(S)-2'-Oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic Acid chemical structure](/media/structures/JZRARRAPRCNVSS-HNNXBMFYSA-N.svg)
(S)-2'-Oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic Acid
- CAS
- 1375541-21-1
- Formula
- C15H11N3O3
- MW
- 281.27 g/mol
VQ-028574
tert-Butyl ((3R,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)carbamate
- CAS
- 1456803-36-3
- Formula
- C19H25F3N2O3
- MW
- 386.4 g/mol
VQ-044820
tert-Butyl ((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)carbamate
- CAS
- 1456803-35-2
- Formula
- C19H25F3N2O3
- MW
- 386.4 g/mol
VQ-044819
FAQs — Ubrogepant impurities
Which Ubrogepant impurities do you supply?
We list 7 Ubrogepant-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Ubrogepant impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Ubrogepant impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Ubrogepant impurity standards
We reply within one business day with price, pack options, lead time and documentation.